Featuring: Robert Kushner, MD
Robert Kushner, MD explores nutrition and weight management with Semaglutide. He shares how Semaglutide is changing the approach for treating patients and on average, how long patients need to be on it to reach full effectiveness.
He talks about how he is incorporating these findings into his work at Northwestern Medicine and how this study can impact weight management research and potentially other treatment options for patients in the future
Dr. Kushner, professor of Medicine in the Division of Endocrinology, was honored by the Clinical Research Forum with a 2022 Top 10 Clinical Research Achievement Award.
Kushner and his collaborators found a new anti-obesity medication was almost twice as effective at helping individuals lose weight than many of the current weight-loss drugs on the market, according to findings published in The New England Journal of Medicine.
“I am honored to be recognized by the Clinical Research Forum for our seminal study published in The New England Journal of Medicine,” said Kushner, who was corresponding author of the study and is also a professor of Medical Education. “The award is a tribute to the outstanding study team and the impact of semaglutide in the treatment of people living with obesity.”
Robert Kushner, MD, professor of Medical Education and Endocrinology in the department of Medicine.
Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients.